Zobrazeno 1 - 10
of 388
pro vyhledávání: '"Ribi, C."'
Autor:
Hoffmann-Vold A. -M., Brunborg C., Airo P., Ananyeva L. P., Czirjak L., Guiducci S., Hachulla E., Li M., Mihai C., Riemekasten G., Sfikakis P. P., Valentini G., Kowal-Bielecka O., Allanore Y., Distler O., Vacca A., Giollo A., Balbir-Gurman A., Gheorghiu A. M., Marcoccia A., Herrick A., Radic M., Stamenkovic B., Anic B., Granel B., Ribi C., Selmi C. F., Carlos de la Puente M., de Souza Muller C., Denton C., Kayser C., Tanaseanu C. -M., Majewski D., Rimar D., Krasowska D., Veale D., Walker U., Kerzberg E., Rezus E., Zanatta E., Siegert E., De Langhe E., Oksel F., Ingegnoli F., Cantatore F. P., Szucs G., Cuomo G., Seskute G., Litinsky V., Castellvi I., Morovic-Vergles J., Sibilia J., Henes J., Solanki K., Perdan-Pirkmajer K., Herrmann K., Saketkoo L. A., Stamp L., Mouthon L., Salvador M. J., Pozzi M. R., Uprus M., Vanthuyne M., Engelhart M., Kohm M., Iudici M., Inanc M., Fathi N., Pamuk N., Garcia de la Pena Lefebv P., Carreira P. E., Bancel D. F., Moroncini L., Montecucco C., Ancuta C., Sunderkotter C., Muller-Ladner U., Rosato E., Kucharz E. J., Iannone F., Del Galdo F., Poormoghim H., Kotter I., Distler J., Cutolo M., Tikly M., Damjanov N., Hunzelmann N., Vlachoyiannopoulos P., Hasler P., Sarzi Puttini P., Wiland P., Becvar R., Yavuz S., Zdrojewski Z., Pellerito R., Foti R., Ionescu R. M., Adler S., Kahl S., Moiseev S., Stebbings S., Rednic S., Negrini S., Heitmann S., Ullman S., Agachi S., Martin T., Schmeiser T., Riccieri V., Smith V., Bernardino V., Ortiz-Santamaria V., Hsu V. M., Abdel Atty Mohamed W. A.
Publikováno v:
Chest. 163:586-598
BACKGROUND: Enrichment strategies from clinical trials for progressive systemic sclerosis-associated interstitial lung disease (SSc-ILD) have not been tested in a real-life cohort.RESEARCH QUESTION: Do enrichment strategies for progressive ILD impact
Autor:
Redelman-Sidi, G., Michielin, O., Cervera, C., Ribi, C., Aguado, J.M., Fernández-Ruiz, M., Manuel, O.
Publikováno v:
In Clinical Microbiology and Infection June 2018 24 Supplement 2:S95-S107
Autor:
Ringwald, M., Chevalley, D., Bongard, C., Kissling, S., Rotman, S., Von Garnier, C., Ribi, C., Comte, D.
Publikováno v:
Revue medicale suisse, vol. 19, no. 821, pp. 674-679
Within the group of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides, granulomatosis with polyangiitis (GPA) is the most frequent. The incidence is around 10 to 20 cases/million/year. Clinical manifestations are varied, with ENT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::3222ba0cd60e50788caf3af33c91d7ca
https://serval.unil.ch/notice/serval:BIB_D369BEFFD011
https://serval.unil.ch/notice/serval:BIB_D369BEFFD011
Publikováno v:
Revue medicale suisse, vol. 19, no. 821, pp. 680-685
Anti-glomerular basement membrane disease is a rare disease. In its classical presentation it associates rapidly progressive glomerulonephritis and diffuse alveolar hemorrhage, linked to the presence of antibodies targeting type IV collagen in the gl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::a5019bced5305c55f093e0975e2a60cf
https://serval.unil.ch/notice/serval:BIB_89863117120D
https://serval.unil.ch/notice/serval:BIB_89863117120D
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tachet, J., Dumusc, A., Conrad, C., Grandoni, F., Chalandon, Y., Ribi, C., Buclin, T., Girardin, F.
Publikováno v:
Revue medicale suisse, vol. 18, no. 800, pp. 1979-1983
Janus kinase inhibitors (JAKi), such as tofacitinib, baricitinib, upadacitinib or ruxolitinib, are small molecules active on specific intracellular targets and used orally for the treatment of autoimmune or myeloproliferative diseases. Their remarkab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::8b27fb520f693fc48da446f90c9286c1
https://serval.unil.ch/notice/serval:BIB_0D12F79D0C49
https://serval.unil.ch/notice/serval:BIB_0D12F79D0C49
Autor:
Bettiol, A., Urban, M. L., Dagna, L., Cottin, V., Franceschini, F., Del Giacco, S., Schiavon, F., Neumann, T., Lopalco, G., Novikov, P., Baldini, C., Lombardi, C., Berti, A., Alberici, F., Folci, M., Negrini, S., Sinico, R. A., Quartuccio, L., Lunardi, C., Parronchi, P., Moosig, F., Espigol-Frigole, G., Schroeder, J., Kernder, A. L., Monti, S., Silvagni, E., Crimi, C., Cinetto, F., Fraticelli, P., Roccatello, D., Vacca, A., Mohammad, A. J., Hellmich, B., Samson, M., Bargagli, E., Cohen Tervaert, J. W., Ribi, C., Fiori, D., Bello, F., Fagni, F., Moroni, L., Ramirez, G. A., Nasser, M., Marvisi, C., Toniati, P., Firinu, D., Padoan, R., Egan, A., Seeliger, B., Iannone, F., Salvarani, C., Jayne, D., Prisco, D., Vaglio, A., Emmi, G., Ahmad, K., Beccalli, M., Bonnotte, B., Bortolotti, R., Cariddi, A., Caminati, M., Cid, M. C., Deidda, M., Delvino, P., Scala, G. D., Felicetti, M., Ferro, F., Furini, F., Gelain, E., Ghirelli, G., Holle, J., Losappio, L. M., Mahr, A., Malandrino, D., Marhhold, J., Mattioli, I., Moi, L., Moiseev, S., Muratore, F., Nolasco, S., Olivieri, B., Palermo, A., Regola, F., Sander, O., Scarpa, R., Sciascia, S., Silvestri, E., Susca, N., Terrier, B., Treppo, E., Trezzi, B., Uzzo, M., Vitiello, G., Yacyshyn, E.
Publikováno v:
Arthritis & Rheumatology, 74(2), 295-306. Wiley
OBJECTIVE: Mepolizumab proved to be an efficacious treatment for eosinophilic granulomatosis with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled MIRRA trial. In a few recently reported studies, successful real-lif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08b0547c43a649df68ec14794659a749
Publikováno v:
Scientific reports, vol. 12, no. 1, pp. 9189
Determining disease activity in systemic lupus erythematosus (SLE) patients is challenging and limited by the lack of reliable biomarkers. Abnormally activated B cells play a key role in the pathogenesis of SLE, but their measure in clinical practice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::5b6c632293952d772447f553207c8a7a
https://serval.unil.ch/notice/serval:BIB_79225BAA39D6
https://serval.unil.ch/notice/serval:BIB_79225BAA39D6
Publikováno v:
Revue medicale suisse, vol. 18, no. 776, pp. 634-638
Anisakis simplex is a parasitic worm. It infects marine mammals that feed on fish and cephalopods, its intermediary hosts. Human disease is caused by accidental ingestion of Anisakis larvae. Upon consumption of contaminated fish, cuttlefish or squid,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::be3166204aefbbc1a91facd58203a10b
https://serval.unil.ch/notice/serval:BIB_C100DD2F9489
https://serval.unil.ch/notice/serval:BIB_C100DD2F9489
Publikováno v:
Revue medicale suisse, vol. 18, no. 776, pp. 639-645
Intravenous iron infusions rarely result in severe hypersensitivity reactions. The primary suspected hypersensitivity mechanism is an abnormal complement activation by non-IgE antibodies to the carbohydrate moieties stabilizing iron formulations. A m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::e0242cb3eae4f556bd01c1cfae6348aa
https://serval.unil.ch/resource/serval:BIB_549B88D4BEB5.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_549B88D4BEB5.P001/REF.pdf